Cardiol Therapeutics (CRDL) Earnings Date & Reports

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CRDL is expected to report earnings to rise 29.66% to -9 cents per share on May 20

Cardiol Therapeutics CRDL Stock Earnings Reports

Q1'25

Est.

$-0.09

Q4'24

Beat

by $0.03

Q3'24

Missed

by $0.05

Q2'24

Beat

by $0.03

Q1'24

Missed

by $0.01

The last earnings report on March 27 showed earnings per share of -6 cents, beating the estimate of -9 cents. With 206.05K shares outstanding, the current market capitalization sits at 124.33M.

View a ticker or compare two or three

Compare

CRDL